These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 9417560)
21. Pharmacological stress cardiovascular magnetic resonance: feasibility and safety in a large multicentre prospective registry. Monmeneu Menadas JV; Lopez-Lereu MP; Estornell Erill J; Garcia Gonzalez P; Igual Muñoz B; Maceira Gonzalez A Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):308-15. PubMed ID: 26108417 [TBL] [Abstract][Full Text] [Related]
22. Comparison of bicycle, heavy isometric, dipyridamole-atropine and dobutamine stress echocardiography for diagnosis of myocardial ischemia. Loimaala A; Groundstroem K; Pasanen M; Oja P; Vuori I Am J Cardiol; 1999 Dec; 84(12):1396-400. PubMed ID: 10606111 [TBL] [Abstract][Full Text] [Related]
23. Pharmacologic stress testing: experience with dipyridamole, adenosine, and dobutamine. McGuinness ME; Talbert RL Am J Hosp Pharm; 1994 Feb; 51(3):328-46; quiz 404-5. PubMed ID: 8160685 [TBL] [Abstract][Full Text] [Related]
24. Verification of the left ventricular ejection fraction from gated myocardial perfusion studies (GSPECT). Teresińska A; Wnuk J; Konieczna S; Dabrowski A Kardiol Pol; 2005 Nov; 63(5):465-75; discussion 476-7. PubMed ID: 16362849 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine. Schröder K; Völler H; Dingerkus H; Münzberg H; Dissmann R; Linderer T; Schultheiss HP Am J Cardiol; 1996 May; 77(11):909-14. PubMed ID: 8644637 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups. Pingitore A; Picano E; Varga A; Gigli G; Cortigiani L; Previtali M; Minardi G; Colosso MQ; Lowenstein J; Mathias W; Landi P J Am Coll Cardiol; 1999 Nov; 34(6):1769-77. PubMed ID: 10577568 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: a comparison between dobutamine and dipyridamole. Salustri A; Fioretti PM; McNeill AJ; Pozzoli MM; Roelandt JR Eur Heart J; 1992 Oct; 13(10):1356-62. PubMed ID: 1396808 [TBL] [Abstract][Full Text] [Related]
29. Comparing a high-dose dipyridamole SPECT imaging protocol with dobutamine and exercise stress testing protocols. Fleming RM; Rose CH; Feldmann KM Angiology; 1995 Jul; 46(7):547-56. PubMed ID: 7618757 [TBL] [Abstract][Full Text] [Related]
30. The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups. Pingitore A; Picano E; Colosso MQ; Reisenhofer B; Gigli G; Lucarini AR; Petix N; Previtali M; Bigi R; Chiarandà G; Minardi G; de Alcantara M; Lowenstein J; Sclavo MG; Palmieri C; Galati A; Seveso G; Heyman J; Mathias W; Casazza F; Sicari R; Raciti M; Landi P; Marzilli M J Am Coll Cardiol; 1996 Apr; 27(5):1164-70. PubMed ID: 8609337 [TBL] [Abstract][Full Text] [Related]
31. Head-to-head comparison of dipyridamole, dobutamine and pacing stress echocardiography for the detection of myocardial ischemia in an animal model of coronary artery stenosis. Schmidt A; de Almeida-Filho OC; Ayres-Neto EM; Carneiro JJ; Marin-Neto JA; Maciel BC Braz J Med Biol Res; 2001 Jul; 34(7):903-11. PubMed ID: 11449309 [TBL] [Abstract][Full Text] [Related]
32. Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients. Cortigiani L; Zanetti L; Bigi R; Desideri A; Fiorentini C; Nannini E J Hypertens; 2002 Jul; 20(7):1423-9. PubMed ID: 12131540 [TBL] [Abstract][Full Text] [Related]
33. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. Dagianti A; Penco M; Agati L; Sciomer S; Dagianti A; Rosanio S; Fedele F J Am Coll Cardiol; 1995 Jul; 26(1):18-25. PubMed ID: 7797748 [TBL] [Abstract][Full Text] [Related]
34. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis. Kim C; Kwok YS; Heagerty P; Redberg R Am Heart J; 2001 Dec; 142(6):934-44. PubMed ID: 11717594 [TBL] [Abstract][Full Text] [Related]
35. Dipyridamole-dobutamine stress echocardiography for the detection of myocardial ischemia in patients with hypertension. Milosavljevic J; Ostojic M; Marinkovic J Herz; 2005 May; 30(3):215-22. PubMed ID: 15902372 [TBL] [Abstract][Full Text] [Related]
36. Diagnosing coronary heart disease: when to use stress imaging studies. Hayes SN; McBride P J Fam Pract; 2003 Jul; 52(7):544-51. PubMed ID: 12841971 [No Abstract] [Full Text] [Related]
38. Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Martin TW; Seaworth JF; Johns JP; Pupa LE; Condos WR Ann Intern Med; 1992 Feb; 116(3):190-6. PubMed ID: 1728203 [TBL] [Abstract][Full Text] [Related]
39. Relation between ischemic threshold measured during dobutamine stress echocardiography and known indices of poor prognosis in patients with coronary artery disease. Panza JA; Curiel RV; Laurienzo JM; Quyyumi AA; Dilsizian V Circulation; 1995 Oct; 92(8):2095-101. PubMed ID: 7554187 [TBL] [Abstract][Full Text] [Related]
40. Stress-induced ST-segment elevation following myocardial infarction and its role in wall motion abnormality, myocardial ischemia and viability: comparison of response to exercise, dobutamine and dipyridamole. Yamamoto T; Miyazaki T; Hirano Y; Ishikawa K Jpn Circ J; 2001 Dec; 65(12):1029-33. PubMed ID: 11767993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]